Skip to main content

Table 3 Hazard ratios for dying after admission for acute exacerbation of COPD

From: NT-proBNP independently predicts long term mortality after acute exacerbation of COPD – a prospective cohort study

Variable

All patients*

Patients with no history of heart failure†

Patients with no chest pain or ischemia‡

 

Univariate

Adjusted

Adjusted

Adjusted

 

Hazard ratio (95% CI)

p-value

Hazard ratio (95% CI)

p-value

Hazard ratio (95% CI)

p-value

Hazard ratio (95% CI)

p-value

Age, per 5 years

1.3 (1.08-1.5)

0.003

0.99 (0.83-1.2)

0.872

0.95 (0.78-1.2)

0.643

0.98 (0.75-1.3)

0.860

Female

1.4 (0.81-2.3)

0.252

2.0 (1.1-3.6)

0.020

1.7 (0.87-3.3)

0.119

2.8 (1.2-6.8)

0.020

Peripheral edema

3.2 (1.9-5.5)

<0.0001

2.1 (1.2-3.8)

0.014

2.1 (1.0-4.2)

0.044

2.6 (1.1-6.1)

0.032

Cephalization

4.5 (2.5-8.0)

<0.0001

2.2 (1.2-4.2)

0.014

2.2 (1.0-4.8)

0.049

3.4 (1.2-9.8)

0.022

hs-cTnT, ng/L

 

p for trend 0.0001

 

p for trend 0.004

 

p for trend 0.008

 

p for trend 0.004

<14

1

 

1

 

1

 

1

 

14-40

6.3 (1.9-21)

0.003

4.3 (1.2-15)

0.024

4.5 (1.3-16)

0.021

9.4 (1.2-77)

0.036

≥40

12 (3.5-38)

<0.0001

6.5 (1.8-24)

0.005

6.4 (1.7-24)

0.007

16 (1.7-140)

0.013

NT-proBNP, tertile

 

p for trend <0.0001

 

p for trend 0.013

 

p for trend 0.030

 

p for trend 0.211

1(< 264.4 pg/mL)

1

 

1

 

1

 

1

 

2 (264.4-909 pg/mL)

4.3 (1.8-10)

0.0009

2.4 (0.95-6.0)

0.064

2.7 (1.0-7.4)

0.049

2.1 (0.60-7.5)

0.247

3 (≥ 909 pg/mL)

6.9 (3.0-16)

<0.0001

3.2 (1.3-8.1)

0.012

3.3 (1.2-9.1)

0.023

2.5 (0.59-9.0)

0.167

  1. *Based on 217 admissions and 57 mortalities among 99 patients in an extended Cox analysis with time dependent covariables. †Based on 185 admissions among 85 patients (46 mortalities). ‡Based on 137 admissions among 64 patients (30 mortalities). hs-cTnT, high-sensitivity cardiac troponin T.